Circulating Biomarkers for Duchenne Muscular Dystrophy. - Test2 - elhamkhani - TriplyDB

Circulating Biomarkers for Duchenne Muscular Dystrophy.

Circulating Biomarkers for Duchenne Muscular Dystrophy.

http://www.wikidata.org/entity/Q37610530

about

Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.

P2860

Q42209543-F154F9DA-1846-4429-A9BF-18B7A310830D Q52372774-61AD20DD-4CD9-43F0-B8E9-42561E870AB1

P2860

Circulating Biomarkers for Duchenne Muscular Dystrophy.

http://www.wikidata.org/entity/Q37610530

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Circulating Biomarkers for Duchenne Muscular Dystrophy.

@en

Circulating Biomarkers for Duchenne Muscular Dystrophy.

@nl

type

label

Circulating Biomarkers for Duchenne Muscular Dystrophy.

@en

Circulating Biomarkers for Duchenne Muscular Dystrophy.

@nl

prefLabel

Circulating Biomarkers for Duchenne Muscular Dystrophy.

@en

Circulating Biomarkers for Duchenne Muscular Dystrophy.

@nl

P1433

Q37610530-F468A7DB-BBD1-4CE8-B010-6981C56F629E

P1476

Q37610530-609A89AF-CC84-45D8-A52F-AE352D7982AE

P2093

Q37610530-1E91BBFA-F73A-46C8-8BF3-BB3E6F2C510E

P2860

Q37610530-01BB6BAD-93ED-440D-A08A-DF969C1A6E7C

Q37610530-037165EC-C72F-412B-84DA-5DBEFB5AAED8

Q37610530-04C10C19-F8E2-4EF6-9D0D-F689A017A643

Q37610530-0526807E-D8BD-4940-9AD8-BCF6EBB2D4F6

Q37610530-0A17C2DC-43EA-4E84-8354-D3E2BB34AFEB

Q37610530-0C893BB5-2F81-4147-BB1B-BF2B4F6516DE

Q37610530-147CC8D9-B269-4116-B044-76A66B78292C

Q37610530-14B08780-1448-41BB-B564-E3163B07ED10

Q37610530-17F22330-1B1C-4435-8591-90619F88F574

Q37610530-19D7610D-8727-459D-8C0A-B539D0D6B784

P304

Q37610530-A2964175-7135-40C4-AA49-87A02874041C

P31

Q37610530-9F2D568C-3143-416C-8434-9A854DC6212D

P356

Q37610530-0EA8FB43-65D2-43B1-8AC9-75B5AD1111E8

P433

Q37610530-1605F4A7-B13D-43F4-8F28-B17340FED73F

P478

Q37610530-EAA73F7B-FB95-4146-ACD9-750273225AAF

P50

Q37610530-0A2917F6-9075-4E94-8C5E-EEBCAD91B6E4

Q37610530-9FEB82AF-B278-447F-933C-F72B337A6B3E

P577

Q37610530-6A7EF685-4965-407E-BB8A-E5468CA3CD55

P698

Q37610530-B708F954-EC09-4FF7-8A11-B45355F1A017

P921

Q37610530-1B78B295-B033-4EFA-8982-334F7F54456D

P932

Q37610530-CF75CC47-71C4-4D9F-8B40-14ADCC413FD2

P356

P1433

Journal of neuromuscular diseases

P1476

Circulating Biomarkers for Duchenne Muscular Dystrophy

@en

P2093

Pietro Spitali

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle

miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

Distinctive patterns of microRNA expression in primary muscular disorders

Biomarkers and surrogate endpoints

Sources of variability and effect of experimental approach on expression profiling data interpretation

Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMD

P304

S49-S58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JND-150102

http://www.w3.org/2001/XMLSchema#string

P433

s2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Annemieke Aartsma-Rus

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27858763

http://www.w3.org/2001/XMLSchema#string

P921

P932

5271432

http://www.w3.org/2001/XMLSchema#string